Progyny Inc. (PGNY) Insider Trading

Last 12 months

Insiders bought $1.93M and sold $2.31M on the open market.

70% of the selling was scheduled in advance under 10b5-1 plans. Director Kevin K Gordon sold $312k on Sep 10, 63% of their stake, outside a plan.

Net open-market

−$374k

1 buy · 20 sales

Under a 10b5-1 plan

70%

of the value sold

Insiders who bought / sold

1 / 6

executives and directors

Last open-market buy

Nov 2025

Nov 13, 2025

Get an email when PGNY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 14	Melissa B Cummings Chief Operating Officer	Sold10b5-1 plan	1,879	$28.00	$53k	2.7%	Form 4
Sep 23	Allison Swartz EVP, GC	Sold10b5-1 plan	3,903	$26.10	$102k	4.9%	Form 4
Sep 10	Kevin K Gordon Director	SoldNo plan	11,500	$27.12	$312k	63%	Form 4
Jul 14	Melissa B Cummings Chief Operating Officer	Sold10b5-1 plan	2,244	$31.60	$71k	3.1%	Form 4
Jun 4	Mark S. Livingston CHIEF FINANCIAL OFFICER	Sold10b5-1 plan 2 parts	2,517	$25.50 average	$64k	3.3%	Form 4
Jun 3 – 4	Allison Swartz EVP, GC	Sold10b5-1 plan 2 parts	1,798	$25.04 average	$45k	2.1%	Form 4
Jun 2	Mark S. Livingston CHIEF FINANCIAL OFFICER	Sold10b5-1 plan	279	$26.20	$7k	0.4%	Form 4
Jun 2	Geoffrey Clapp Chief Product Officer	SoldNo plan	1,530	$25.58	$39k	2.5%	Form 4
Jun 1	Cheryl Scott Director	SoldNo plan	7,439	$26.39	$196k	27%	Form 4
May 28	Allison Swartz EVP, GC	Sold10b5-1 plan	2,398	$25.46	$61k	2.7%	Form 4
May 27	Kevin K Gordon Director	SoldNo plan	5,500	$24.99	$137k	20%	Form 4
May 20	Mark S. Livingston CHIEF FINANCIAL OFFICER	Sold10b5-1 plan	8,275	$25.50	$211k	9.5%	Form 4
May 19	Melissa B Cummings Chief Operating Officer	Sold10b5-1 plan	9,578	$25.00	$239k	12%	Form 4
Mar 4	Allison Swartz EVP, GC	Sold10b5-1 plan	599	$17.54	$11k	0.7%	Form 4
Mar 2 – 3	Allison Swartz EVP, GC	Sold10b5-1 plan 3 parts	6,856	$17.36 average	$119k	7.1%	Form 4
Dec 11, 2025	Mark S. Livingston CHIEF FINANCIAL OFFICER	Sold10b5-1 plan	459	$25.50	$12k	1.0%	Form 4
Dec 4, 2025	Allison Swartz EVP, GC	Sold10b5-1 plan	530	$24.59	$13k	0.7%	Form 4
Dec 2, 2025	Mark S. Livingston CHIEF FINANCIAL OFFICER	Sold10b5-1 plan	213	$25.50	$5k	0.4%	Form 4
Nov 28, 2025	Allison Swartz EVP, GC	Sold10b5-1 plan	2,398	$26.87	$64k	3.2%	Form 4
Nov 17, 2025	Mark S. Livingston CHIEF FINANCIAL OFFICER	Sold10b5-1 plan	21,303	$25.50	$543k	31%	Form 4
Nov 13, 2025	Peter Anevski CHIEF EXECUTIVE OFFICER	Bought	79,500	$24.29	$1.93M	13%	Form 4
Sep 4, 2025	Allison Swartz EVP, GC	Sold10b5-1 plan	599	$23.53	$14k	0.8%	Form 4
Aug 28, 2025	Allison Swartz EVP, GC	Sold10b5-1 plan	2,398	$22.96	$55k	3.0%	Form 4
Aug 11, 2025	Kevin K Gordon Director	SoldNo plan	2,500	$22.04	$55k	11%	Form 4
Jun 11, 2025	Cheryl Scott Director	SoldNo plan	2,675	$22.07	$59k	16%	Form 4
Dec 26, 2024	David J Schlanger Executive Chairman	Bought	150,000	$14.68	$2.2M	192%	Form 4
Dec 23, 2024	Peter Anevski CHIEF EXECUTIVE OFFICER	Bought	209,500	$14.48	$3.03M	90%	Form 4

Oct 1410b5-1 plan
Melissa B Cummings
Chief Operating Officer · sold 1,879 at $28.00
$53k
2.7% of stake
Sep 2310b5-1 plan
Allison Swartz
EVP, GC · sold 3,903 at $26.10
$102k
4.9% of stake
Sep 10No plan
Kevin K Gordon
Director · sold 11,500 at $27.12
$312k
63% of stake
Jul 1410b5-1 plan
Melissa B Cummings
Chief Operating Officer · sold 2,244 at $31.60
$71k
3.1% of stake
Jun 410b5-1 plan
Mark S. Livingston
CHIEF FINANCIAL OFFICER · sold 2,517 at avg $25.50
$64k
3.3% of stake
Jun 3 – 410b5-1 plan
Allison Swartz
EVP, GC · sold 1,798 at avg $25.04
$45k
2.1% of stake
Jun 210b5-1 plan
Mark S. Livingston
CHIEF FINANCIAL OFFICER · sold 279 at $26.20
$7k
0.4% of stake
Jun 2No plan
Geoffrey Clapp
Chief Product Officer · sold 1,530 at $25.58
$39k
2.5% of stake
Jun 1No plan
Cheryl Scott
Director · sold 7,439 at $26.39
$196k
27% of stake
May 2810b5-1 plan
Allison Swartz
EVP, GC · sold 2,398 at $25.46
$61k
2.7% of stake
May 27No plan
Kevin K Gordon
Director · sold 5,500 at $24.99
$137k
20% of stake
May 2010b5-1 plan
Mark S. Livingston
CHIEF FINANCIAL OFFICER · sold 8,275 at $25.50
$211k
9.5% of stake
May 1910b5-1 plan
Melissa B Cummings
Chief Operating Officer · sold 9,578 at $25.00
$239k
12% of stake
Mar 410b5-1 plan
Allison Swartz
EVP, GC · sold 599 at $17.54
$11k
0.7% of stake
Mar 2 – 310b5-1 plan
Allison Swartz
EVP, GC · sold 6,856 at avg $17.36
$119k
7.1% of stake
Dec 11, 202510b5-1 plan
Mark S. Livingston
CHIEF FINANCIAL OFFICER · sold 459 at $25.50
$12k
1.0% of stake
Dec 4, 202510b5-1 plan
Allison Swartz
EVP, GC · sold 530 at $24.59
$13k
0.7% of stake
Dec 2, 202510b5-1 plan
Mark S. Livingston
CHIEF FINANCIAL OFFICER · sold 213 at $25.50
$5k
0.4% of stake
Nov 28, 202510b5-1 plan
Allison Swartz
EVP, GC · sold 2,398 at $26.87
$64k
3.2% of stake
Nov 17, 202510b5-1 plan
Mark S. Livingston
CHIEF FINANCIAL OFFICER · sold 21,303 at $25.50
$543k
31% of stake
Nov 13, 2025
Peter Anevski
CHIEF EXECUTIVE OFFICER · bought 79,500 at $24.29
$1.93M
13% of stake
Sep 4, 202510b5-1 plan
Allison Swartz
EVP, GC · sold 599 at $23.53
$14k
0.8% of stake
Aug 28, 202510b5-1 plan
Allison Swartz
EVP, GC · sold 2,398 at $22.96
$55k
3.0% of stake
Aug 11, 2025No plan
Kevin K Gordon
Director · sold 2,500 at $22.04
$55k
11% of stake
Jun 11, 2025No plan
Cheryl Scott
Director · sold 2,675 at $22.07
$59k
16% of stake
Dec 26, 2024
David J Schlanger
Executive Chairman · bought 150,000 at $14.68
$2.2M
192% of stake
Dec 23, 2024
Peter Anevski
CHIEF EXECUTIVE OFFICER · bought 209,500 at $14.48
$3.03M
90% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PGNY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Misc Health & Allied Services, NEC

SHCSotera Health Company

VMDViemed Healthcare Inc.

QIPTQuipt Home Medical Corp.

FMSFresenius Medical Care AG - Depositary Receipt

AGLAgilon Health Inc.

CONConcentra Group Holdings Inc.

ACHCAcadia Healthcare Company, Inc.

GHGuardant Health Inc.

Spot a number that looks wrong? Check it in PGNY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PGNY

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.